CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy | World Journal of Surgical Oncology | Full Text
Serum carcinoembryonic antigen elevation in benign lung diseases | Scientific Reports
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library
Change of preoperative tumor marker levels (cutoff 20%) compared with... | Download Table
A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-2-full.png "The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]")
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer - ScienceDirect
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports
Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library
ABYNTEK | Tumor markers for cancer research: FAQS
Understanding The CEA Test in Colon Cancer - CancerConnect
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
CEA Biomarker | Colorectal Cancer Alliance
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
Impact of Different Selectivity between Soluble and Membrane-bound Forms of Carcinoembryonic Antigen (CEA) on the Target-mediated Disposition of Anti-CEA Monoclonal Antibodies | Drug Metabolism & Disposition
Alteration of tumor markers may predict survival in colorectal cancer patients treated with TAS-102 or regorafenib as salvage-line chemotherapy: a single-institutional experience
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research
Tumor Marker:- Part 11 - Carcinoembryonic Antigen (CEA) - Labpedia.net
Tumor marker change and response rate in patients with elevated... | Download Table
